A Double-Blind Discontinuation Study of Levetiracetam in Post- Traumatic Stress Disorder.

Trial Profile

A Double-Blind Discontinuation Study of Levetiracetam in Post- Traumatic Stress Disorder.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Post-traumatic stress disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Aug 2008 Actual end date is now 1 March 2008 as reported by ClinicalTrials.gov.
    • 13 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Aug 2008 Actual patient number is 16 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top